Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment

Translational Lung Cancer Research

Volumn 3, Issue 2, 2014, Pages 100-106

  Nel, Ivonne ^a   Jehn, Ulrich ^a   Gauler, Thomas ^a   Hoffmann, Andreas Claudius ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Circulating tumor cells (CTC); Epithelial cells; Mesenchymal cells; Stem cell like

Indexed keywords

CARBOPLATIN; CD133 ANTIGEN; CD45 ANTIGEN; CISPLATIN; CYTOKERATIN; EPITHELIAL CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE; PACLITAXEL; PEMETREXED;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELL COMPOSITION; CELL SUSPENSION; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CLINICAL FEATURE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUNG ADENOCARCINOMA; MULTIPLE CYCLE TREATMENT; NON SMALL CELL LUNG CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PROGRESSION FREE SURVIVAL; SQUAMOUS CELL LUNG CARCINOMA; TREATMENT RESPONSE;

EID: 84927150847     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.3978/j.issn.2218-6751.2014.03.05     Document Type: Article

References (22)

1. Lianidou ES, Markou A. Circulating tumor cells as emerging tumor biomarkers in breast cancer. Clin Chem Lab Med 2011;49:1579-90.
2. O'Flaherty JD, Gray S, Richard D, et al. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer 2012;76:19-25.
3. Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004;10:6897-904.
4. Hou JM, Krebs M, Ward T, et al. Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol 2011;178:989-96.
5. Moldenhauer G, Momburg F, Möller P, et al. Epitheliumspecific surface glycoprotein of Mr 34, 000 is a widely distributed human carcinoma marker. Br J Cancer 1987;56:714-21.
6. Zhang N, Li X, Wu CW, et al. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene 2013;32:5078-88.
7. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-91.
8. Gauler TC, Theegarten D, Parr A, et al. Decrease of circulating tumor cells associates with response to platinum-based chemotherapy in patients with non-small cell lung cancer, but not with small cell lung cancer. J Thorac Oncol 2011;6:S1114.
9. Alix-Panabières C, Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem 2013;59:110-8.
10. Nel I, Baba HA, Ertle J, et al. Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma. Transl Oncol 2013;6:420-8.
11. Nel I, Gauler TC, Eberhardt WE, et al. Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment. Br J Cancer 2013;109:1223-9.
12. Nel I, Gauler T, Hoffmann AC. Circulating tumor cell composition and outcome in patients with solid tumors. Int J Clin Pharmacol Ther 2014;52:74-5.
13. Sobin LH. TNM: evolution and relation to other prognostic factors. Semin Surg Oncol 2003;21:3-7.
14. Therasse P, Arbuck SG, Eisenhauer EA, New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
15. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-47.
16. Hoffmann AC, Wild P, Leicht C, et al. MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia 2010;12:628-36.
17. Hoffmann AC, Danenberg KD, Taubert H, et al. A threegene signature for outcome in soft tissue sarcoma. Clin Cancer Res 2009;15:5191-8.
18. Sarkar FH, Li Y, Wang Z, et al. Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir 2009;64:489-500.
19. Barr MP, Gray SG, Hoffmann AC, et al. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. PLoS One 2013;8:e54193.
20. Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013;339:580-4.
21. Yu M, Stott S, Toner M, et al. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011;192:373-82.
22. Joly E, Hudrisier D. What is trogocytosis and what is its purpose? Nat Immunol 2003;4:815.